Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model

H. Xu; E. Elster; D. Batty; J. Berning; L. Burkly; R. Kampen; S. Swanson; D. Tadaki; D. Harlan; A. Kirk

doi:10.1016/S0041-1345(00)01983-7

Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model

H. Xu, E. Elster, D. Batty, J. Berning, L. Burkly, R. Kampen, S. Swanson, D. Tadaki, D. Harlan, A. Kirk^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Original language	English
Pages (from-to)	223-224
Number of pages	2
Journal	Transplantation Proceedings
Volume	33
Issue number	1-2
DOIs	https://doi.org/10.1016/S0041-1345(00)01983-7
State	Published - 2001
Externally published	Yes

Access to Document

10.1016/S0041-1345(00)01983-7

Cite this

@article{66aba1ff73aa4b0495f32cafa5006833,

title = "Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model",

author = "H. Xu and E. Elster and D. Batty and J. Berning and L. Burkly and R. Kampen and S. Swanson and D. Tadaki and D. Harlan and A. Kirk",

note = "Funding Information: Supported by Naval Medical Research and Development Command Grant EW.0095.003.1412, National Institutes of Health Grant AI43900-01, Office of Naval Research Grant N00014-96-1-1282, and a grant from Biogen, Inc. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of the Navy, the Department of Defense, or the United States Government. ",

year = "2001",

doi = "10.1016/S0041-1345(00)01983-7",

language = "English",

volume = "33",

pages = "223--224",

journal = "Transplantation Proceedings",

issn = "0041-1345",

publisher = "Elsevier Inc.",

number = "1-2",

}

TY - JOUR

T1 - Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model

AU - Xu, H.

AU - Elster, E.

AU - Batty, D.

AU - Berning, J.

AU - Burkly, L.

AU - Kampen, R.

AU - Swanson, S.

AU - Tadaki, D.

AU - Harlan, D.

AU - Kirk, A.

N1 - Funding Information: Supported by Naval Medical Research and Development Command Grant EW.0095.003.1412, National Institutes of Health Grant AI43900-01, Office of Naval Research Grant N00014-96-1-1282, and a grant from Biogen, Inc. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of the Navy, the Department of Defense, or the United States Government.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0035084115&partnerID=8YFLogxK

U2 - 10.1016/S0041-1345(00)01983-7

DO - 10.1016/S0041-1345(00)01983-7

M3 - Article

C2 - 11266788

AN - SCOPUS:0035084115

SN - 0041-1345

VL - 33

SP - 223

EP - 224

JO - Transplantation Proceedings

JF - Transplantation Proceedings

IS - 1-2

ER -

Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model

Access to Document

Fingerprint

Cite this